×
Acuren EBIT Margin 2023-2025 | TIC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
Acuren ebit margin from 2023 to 2025. Ebit margin can be defined as earnings before interest and taxes as a portion of total revenues
View More
Acuren EBIT Margin 2023-2025 | TIC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
Acuren ebit margin from 2023 to 2025. Ebit margin can be defined as earnings before interest and taxes as a portion of total revenues
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$230.9B
Boston Scientific (BSX)
$156.3B
Stryker (SYK)
$149.6B
EssilorLuxottica (ESLOY)
$141.3B
Medtronic (MDT)
$119B
Lonza Group Ag (LZAGY)
$49.8B
Haleon (HLN)
$44B
ResMed (RMD)
$40.2B
Agilent Technologies (A)
$35.7B
GE HealthCare Technologies (GEHC)
$33.7B
Terumo (TRUMY)
$26.6B
Koninklijke Philips (PHG)
$26.6B
Insulet (PODD)
$23.9B
Zimmer Biomet Holdings (ZBH)
$21B
Smith & Nephew SNATS (SNN)
$16.4B
Baxter (BAX)
$12.7B
Sunny Optical Technology (SNPTF)
$10.8B
Demant (WILYY)
$8.1B
Bio-Rad Laboratories (BIO)
$8.1B
Lantheus Holdings (LNTH)
$3.7B
Envista Holdings (NVST)
$3.5B
Shandong Weigao Medical Polymer (SHWGF)
$3.5B
Prestige Consumer Healthcare (PBH)
$3.3B
Perrigo (PRGO)
$3.3B
ICU Medical (ICUI)
$3.2B
Haemonetics (HAE)
$2.6B
Curaleaf Holdings (CURLF)
$2.2B
LeMaitre Vascular (LMAT)
$2.2B
QuidelOrtho (QDEL)
$1.9B
Green Thumb Industries (GTBIF)
$1.8B